Status:
COMPLETED
The Impact of the Previous Exposure to Covid-19 Virus Infection on the Outcome of ICSI Cycles
Lead Sponsor:
Al Baraka Fertility Hospital
Conditions:
COVID-19
IVF
Eligibility:
FEMALE
20-38 years
Brief Summary
Whilst the global COVID-19 pandemic is still evolving and there are many unknowns about the long-term effects of the virus on fertility and pregnancy, we found ourselves in need to offer some evidence...
Detailed Description
This is an observational study, for 122 ICSI cycles conducted in Al- Baraka Fertility Hospital, Manama, Bahrain, and Al-Manea hospital, KSA between August 2020 and May 2021, and it was approved by the...
Eligibility Criteria
Inclusion
- Inclusion criteria were women who got recovered from Covid-19 based upon their history with positive test results confirmed via BeAware Bahrain phone application and Tawakkalna Saudi phone application; with age below 38 yrs., body mass index (BMI) below 30 kg/m2, who underwent antagonist protocol for IVF
- Exclusion criteria were chromosomal and genetic disorders, age\> 38 years, BMI \> 30, abnormal ultrasonogram of the uterine cavity (acquired or congenital), those who underwent long agonist protocol, and those cases with severe male factor, and abnormal embryos not suitable for transfer, we excluded also patients with those who got vaccinated against Covid-19 and those with current infection.
Exclusion
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 2 2021
Estimated Enrollment :
122 Patients enrolled
Trial Details
Trial ID
NCT05198401
Start Date
August 1 2020
End Date
May 2 2021
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kamal Eldin Abdalla Rageh
Cairo, Egypt, 15006